ArticleFrontiers in neurology2024

Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study.

Giovanna Borriello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.